Clinical Trial Update: Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.

View source ↗

Summary

This clinical trial update describes an intravenous infusion study using allogeneic mesenchymal stem cells in patients with chronic liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Allogene MSCs Transplantation, Chronic Liver Diseases Patients | Status: UNKNOWN